Synthesis, characterization and potential applications of multifunctional PEO-PPOPEO-magnetic drug delivery system

Current Medicinal Chemistry

Volumn 19, Issue 30, 2012, Pages 5199-5204

  Dehvari, K ^a   Lin, K S ^a  

^a YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid beta; Drug delivery system; In vivo imaging; Magnetic nanocomposites; Multifunctional nanoparticles; PEO PPO PEO copolymer

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; CONGO RED; COPOLYMER; DAPSONE; DOXORUBICIN; MACROGOL DERIVATIVE; MAGNETIC NANOCOMPOSITE; MAGNETIC NANOPARTICLE; NANOCOMPOSITE; POLOXAMER; POLY(ETHYLENE OXIDE)POLY(PROPYLENE OXIDE)POLY(ETHYLENE OXIDE); SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL ANALYSIS; CONJUGATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; ELECTRON MICROSCOPE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPE; HUMAN; HYDRODYNAMICS; HYDROPHILICITY; HYDROPHOBICITY; MAGNETIC FIELD; MAGNETISM; MOLECULARLY TARGETED THERAPY; MOLECULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; POLYMERIZATION; TRANSMISSION ELECTRON MICROSCOPY; VIBRATION; X RAY DIFFRACTION;

ALZHEIMER DISEASE; CHLORIDES; COLORING AGENTS; CONGO RED; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; FERROUS COMPOUNDS; MAGNETIC PHENOMENA; NANOCOMPOSITES; POLOXAMER; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 84870418670     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803530584     Document Type: Article

References (48)

1. Brambilla, D.; Droumaguet, B.L.; Nicolas, J.; Hashemi, S.H.; Wu, L.P.; Moghimi, S.M.; Couvreur, P.; Andrieux, K. Nanotechnologies for Alzheimer's disease: Diagnosis, therapy, and safety issues. Nanomedicine, 2011, 7, 521-540.
2. Jain, T.K.; Richey, J.; Strand, M.; Leslie-Pelecky, D.L.; Flask, C.A.; Labhasetwar, V. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials, 2008, 29, 4012-4021.
3. Chomoucka, J.; Drbohlavova, J.; Huska, D.; Adam, V.; Kizek, R.; Hubalek, J. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res., 2010, 62, 144-149.
4. Nishijima, S., Mishima F., Tabata Y., Iseki H., Muragaki Y., Sasaki A. and Saho N. Research and development of magnetic drug delivery system using bulk high temperature superconducting magnet, IEEE T. Appl. Supercon,. 2009, 19, 2257-2260.
5. Medeiros, S.F.; Santos, A.M.; Fessi, H.; Elaissari, A. Stimuli-responsive magnetic particles for biomedical applications. Int. J. Pharm., 2011, 403, 139-161.
6. Figuerola, A.; Di Corato, R.; Manna, L.; Pellegrino, T. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol. Res., 2010, 62, 126-143.
7. Jain, T.K.; Morales, M.A.; Sahoo, S.K.; Leslie-Pelecky, D.L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm., 2005, 2, 194-205.
8. Kievit, F.M.; Zhang, M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc. Chem. Res., 2011, 44, 853-862.
9. Qiang, Y.; Antony, J.; Sharma, A.; Nutting, J.; Sikes, D.; Meyer, D. Iron/iron oxide core-shell nanoclusters for biomedical applications. J. Nanopart. Res., 2006, 8, 489-496.
10. Oh, J.K.; Park, J.M. Iron oxide-based superparamagnetic polymeric nanomaterials: Design, preparation, and biomedical application. Prog. Polym. Sci., 2011, 36, 168-189.
11. Veiseh, O.; Gunn, J.W.; Zhang, M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Delivery Rev., 2010, 62, 284-304.
12. Gonzales, M.; Krishnan, K.M. Phase transfer of highly monodisperse iron oxide nanocrystals with Pluronic F127 for biomedical applications. J. Magn. Magn. Mater., 2007, 311, 59-62.
13. Yallapu, M.M.; Othman, S.F.; Curtis, E.T.; Gupta, B.K.; Jaggi, M.; Chauhan, S.C. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials, 2011, 32, 1890-1905.
14. Tomitaka, A.; Ueda, K.; Yamada, T.; Takemura, Y. Heat dissipation and magnetic properties of surface-coated Fe3O4 nanoparticles for biomedical applications. J. Magn. Magn. Mater., 2012, In press.
15. Zhang, L.; Pornpattananangku, D., Hu, C.J.; Huang, C.M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem., 2010, 17, 585-94.
16. Huang, C.; Tang, Z.; Zhou, Y.; Zhou, X.; Jin, Y.; Li, D.; Yang, Y.; Zhou, S. Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy. Int. J. Pharm., 2012, 429, 113-122.
17. 4 nanoparticles with robust incorporation of doxorubicin by thermo-responsiveness. Int. J. Pharm., 2012, 424, 107-114.
18. Mahmood, I.; Guo, C.; Xia, H.; Ma, J.; Jiang, Y.; Liu, H. Lipase immobilization on oleic acid-Pluronic (l-64) block copolymer coated magnetic nanoparticles, for hydrolysis at the oil/water interface. Ind. Eng. Chem. Res., 2008, 47, 6379-6385.
19. Liu, T.Y.; Hu, S.H.; Liu, K.H.; Shaiu, R.S.; Liu, D.M.; Chen, S.Y. Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field. Langmuir, 2008, 24, 13306-13311.
20. Yang, L.; Guo, C.; Jia, L.; Xie, K.; Shou, Q.; Liu, H. Fabrication of biocompatible temperature- and pH-responsive magnetic nanoparticles and their reversible agglomeration in aqueous milieu. Ind. Eng. Chem. Res., 2010, 49, 8518-8525.
21. Chen, S.; Li, Y.; Guo, C.; Wang, J.; Ma, J.; Liang, X.; Yang, L.R.; Liu, H.Z. Temperature-responsive magnetite/PEO-PPO-PEO block copolymer nanoparticles for controlled drug targeting delivery. Langmuir, 2007, 23, 12669-12676.
22. Glenner, G.G.; Wong, C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120, 885-890.
23. Maurer, K.; Jucker, M.; Beyreuther, K.; Haass, C.; Nitsch, R.M.; Christen, Y. The history of Alois Alzheimer's first case Auguste D Alzheimer's: 100 years and beyond (Research and Perspectives in Alzheimer's disease). Springer: Berlin Heidelberg, 2006; pp. 13-34.
24. Parker, M.; Reitz, A. Assembly of β-amyloid aggregates at the molecular level. Chemtracts: Org. Chem., 2000, 13, 51-56.
25. Shankar, G.; Li, S.; Mehta, T.; Garcia-Munoz, A.; Shepardson, N.; Smith, I.; Brett, F.; Farrell, M.; Rowan, M.; Lemere, C.; Regan, C.; Walsh, D.; Sabatini, B.; Selkoe, D. Amyloid β-protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med., 2008, 14, 837-42.
26. Cheng, I.H.; Scearce-Levie, K.; Legleiter, J.; Palop J.J.; Gerstein, H.; Bien-Ly, N.; Puoliväli, J.; Lesné S.; Ashe K.H.; Muchowski, P.J.; Mucke, A.L. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer's disease mouse models. J. Biol. Chem., 2007, 282, 23818-23828.
27. Extance, A. Alzheimer's failure raises questions about disease-modifying strategies. Nat. Rev. Drug. Discov., 2010, 9, 749-751.
28. Skaat, H.; Margel, S. Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic field. Biochem. Biophys. Res. Commun., 2009, 386, 645-649.
29. Kim, S.; Jensen, J.R.; Cisek, K.; Funk, K.E.; Naphade, S.; Schafer, K.; Kuret, J. Imaging as a strategy for premortem diagnosis and staging of tauopathies. Curr. Alzheimer Res., 2010, 7, 230-234.
30. Shubayev, V.I.; Pisanic, I.T.R.; Jin, S. Magnetic nanoparticles for theragnostics. Adv. Drug Delivery Rev., 2009, 61, 467-477.
31. Lin, K.S.; Chang, N.B.; Chuang, T.D. Fine structure characterization of zerovalent iron nanoparticles for decontamination of nitrites and nitrates in wastewater and groundwater. Sci. Technol. Adv. Mater., 2008, 9, 025015.
32. 3 nanoparticles synthesized under surfactant-free condition by hydrothermal process. J. Alloys Compd., 2010, 500, 206-210.
33. Jain, T.K.; Foy, S.P.; Erokwu, B.; Dimitrijevic, S.; Flask, C.A.; Labhasetwar, V. Magnetic resonance imaging of multifunctional Pluronic stabilized ironoxide nanoparticles in tumor-bearing mice. Biomaterials, 2009, 30, 6748-6756.
34. Lin, J.J.; Chen, J.S.; Huang, S.J.; Ko, J.H.; Wang, Y.M.; Chen, T.L.; Wang, L.F. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials, 2009, 30, 5114-5124.
35. Liu, T.Y.; Hu, S.H.; Hu, S.H.; Tsai, S.P.; Chen, S.Y. Preparation and characterization of thermal-sensitive ferrofluids for drug delivery application. J. Magn. Magn. Mater., 2007, 310, 2850-2852.
36. Foy, S.P.; Manthe, R.L.; Foy, S.T.; Dimitrijevic, S.; Krishnamurthy, N.; Labhasetwar, V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano, 2010, 4, 5217-5224.
37. Lee, K.; Bae, K.H.; Lee, Y.; Lee, S.H.; Ahn, C.H.; Park, T.G. Pluronic/polyethylenimine shell crosslinked nanocapsules with embedded magnetite nanocrystals for magnetically triggered delivery of siRNA. Macromol. Biosci., 2009, 10, 239-245.
38. Triguero, L.; Singh, R.; Prabhakar, R. Molecular dynamics study to investigate the effect of chemical substitutions of methionine 35 on the secondary structure of the amyloid [beta] (A[beta](1-42)) monomer in aqueous solution. J. Phys. Chem. B, 2008, 112, 2159-2167.
39. Haes, A.J.; Hall, W.P.; Chang, L.; Klein, W.L.; Van Duyne, R.P. A localized surface plasmon resonance biosensor: First steps toward an assay for Alzheimer's disease. Nano Lett., 2004, 4, 1029-1034.
40. Atwood, C.S.; Moir, R.D.; Huang, X.; Scarpa, R.C.; Bacarra, N.M. E.; Romano, D.M.; Hartshorn, M.A.; Tanzi, R.E.; Bush, A.I. Dramatic aggregation of Alzheimer's by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem., 1998, 273, 12817-12826.
41. Bush, A.I. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol. Aging, 2002, 23, 1031-1038.
42. Bush, A.I.; Multhaup, G.; Moir, R.D.; Williamson, T.G.; Small, D.H.; Rumble, B.; Pollwein, P.; Beyreuther, K.; Masters, C.L. A novel zinc(II) binding site modulates the function of the β-amyloid protein precursor of Alzheimer's disease. J. Biol. Chem., 1993, 268, 16109-16112.
43. Atwood, C.S.; Scarpa, R.C.; Huang, X.; Moir, R.D.; Jones, W.D.; Fairlie, D.P.; Tanzi, R.E.; Bush, A.I. Characterization of copper interactions with Alzheimer's amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid beta 1-42. J. Neurochem., 2000, 75, 1219-1233.
44. Schenk, D.; Games, D.; Seubert, P. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization. J. Mol. Neurosci., 2001, 17, 259-267.
45. Finefrock, A.E.; Bush, A.I.; Doraiswamy, P.M. Current status of metals as therapeutic targets in Alzheimer's disease. J. Am. Geriatr. Soc., 2003, 51, 1143-1148.
46. Shughrue, P.J.; Acton, P.J.; Breese, R.S.; Zhao, W.Q.; Chen-Dodson, E.; Hepler, R.W.; Wolfe, A.L.; Matthews, M.; Heidecker, G.J.; Joyce, J.G.; Villarreal, S.A.; Kinney, G.G. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiol. Aging, 2010, 31, 189-202.
47. Neef, D.W.; Jaeger, A.M.; Thiele, D.J. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat. Rev. Drug Discov., 2011, 10, 930-944.
48. Kumar, C.S.; Mohammad, F. Magnetic nanomaterials for hyperthermiabased therapy and controlled drug delivery. Adv. Drug Delivery Rev., 2011, 63, 789-808.